Study guide
This chapter is educational content only, not medical advice, and outcomes on any exam depend on many factors beyond any single resource. It spans GI tract and hepatobiliary physiology and pathology, reproductive and endocrine axis mechanisms, metabolic biochemistry and nutrition, and the pharmacology used to treat disorders in these systems, always framed as mechanism-based clinical vignettes consistent with the official content outline.
GI Tract Physiology and Common Pathology
Digestion and absorption depend on coordinated motility, secretion, and enzymatic breakdown, and Step 1 vignettes typically isolate one step in that chain. Gastric parietal cells secrete hydrochloric acid via the H+/K+-ATPase (proton pump) and secrete intrinsic factor, required for vitamin B12 absorption in the terminal ileum; loss of parietal cells in autoimmune (type A) gastritis therefore causes both achlorhydria and B12 deficiency, producing megaloblastic anemia. Peptic ulcer disease arises from an imbalance between mucosal-protective factors (bicarbonate-rich mucus, prostaglandins) and damaging factors (acid, pepsin, Helicobacter pylori, NSAIDs); H. pylori produces urease, which generates ammonia to buffer stomach acid locally, allowing the bacterium to survive and provoke chronic inflammation. NSAIDs cause ulcers by inhibiting cyclooxygenase-1, reducing protective prostaglandin synthesis. Inflammatory bowel disease is a favorite compare-and-contrast topic: Crohn disease can affect any part of the GI tract from mouth to anus, favors the terminal ileum, produces skip lesions with transmural inflammation, and is associated with granulomas, fistulas, and strictures; ulcerative colitis is continuous, limited to the colon and rectum, involves only the mucosa and submucosa, and presents with bloody diarrhea and a risk of toxic megacolon and colorectal cancer proportional to disease duration. Consider an invented patient, Ms. Delgado, a young woman with recurrent right lower quadrant pain, non-bloody diarrhea, and perianal fistulas; this constellation points toward Crohn disease via its transmural, skip-lesion pattern, distinguishing it from the continuous mucosal disease of ulcerative colitis. Malabsorption syndromes, such as celiac disease (an immune reaction to gluten damaging small bowel villi) and lactose intolerance (deficient brush-border lactase), are tested by recognizing which nutrients fail to absorb and the resulting deficiency signs.
Hepatobiliary and Pancreatic Mechanisms
The liver's key roles include bile production, detoxification, protein synthesis, and glucose regulation, and bilirubin metabolism is a classic mechanism topic. Heme breakdown produces unconjugated (indirect) bilirubin, which travels bound to albumin to the liver, where UDP-glucuronosyltransferase conjugates it, making it water-soluble for excretion in bile. Unconjugated hyperbilirubinemia results from increased production (hemolysis), impaired hepatic uptake, or impaired conjugation, as in Gilbert syndrome, a common benign condition with reduced glucuronosyltransferase activity that flares with stress or fasting. Conjugated hyperbilirubinemia points to impaired excretion, from either hepatocellular disease or biliary obstruction; obstruction (by gallstones or a pancreatic head mass) also causes pale stools, dark urine, and pruritus from bile acid deposition. Cirrhosis, the end stage of chronic liver injury, replaces normal architecture with fibrous septa and regenerative nodules, driven by hepatic stellate cells that become activated and deposit collagen; this distorts hepatic blood flow, producing portal hypertension and its downstream effects: esophageal varices, splenomegaly, ascites, and caput medusae. The pancreas contributes exocrine enzymes (lipase, amylase, trypsinogen) essential for digestion, and acute pancreatitis, most often from gallstones or alcohol, results from premature intra-acinar activation of trypsinogen to trypsin, which then activates other proenzymes and causes autodigestion of pancreatic tissue, producing the classic epigastric pain radiating to the back with elevated serum lipase. Chronic pancreatitis leads to both exocrine insufficiency (malabsorption, steatorrhea) and endocrine insufficiency (diabetes) as acinar and islet tissue are progressively destroyed.
Reproductive and Endocrine Axis Physiology
Endocrine physiology on Step 1 centers on feedback loops, and understanding each axis lets you predict what happens when any single hormone is excessive or deficient. The hypothalamic-pituitary-gonadal axis begins with pulsatile GnRH from the hypothalamus, which stimulates LH and FSH from the anterior pituitary; in males, LH stimulates Leydig cells to produce testosterone while FSH acts on Sertoli cells to support spermatogenesis, and in females, FSH promotes follicular growth and estrogen production while a mid-cycle LH surge triggers ovulation. The menstrual cycle is divided into the follicular phase (estrogen-dominant, ending in ovulation) and luteal phase (progesterone-dominant, maintained by the corpus luteum, which regresses without fertilization, causing hormone withdrawal and menses). The hypothalamic-pituitary-thyroid axis involves TRH stimulating TSH, which stimulates thyroid follicular cells to produce T4 and T3; these hormones increase basal metabolic rate and provide negative feedback on the pituitary and hypothalamus. Consider an invented patient, Mr. Nakamura, with weight loss, heat intolerance, tremor, and a suppressed TSH with elevated free T4; this pattern indicates primary hyperthyroidism, with the low TSH reflecting appropriate negative feedback, whereas a high TSH with low T4 would indicate primary hypothyroidism. The hypothalamic-pituitary-adrenal axis involves CRH stimulating ACTH, which stimulates the adrenal cortex to produce cortisol; chronic exogenous steroid use suppresses this axis, so abrupt discontinuation can precipitate adrenal insufficiency because the atrophied adrenal glands cannot immediately resume normal cortisol output. Diabetes mellitus mechanisms differ fundamentally: type 1 results from autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency, while type 2 involves peripheral insulin resistance with a relative insulin deficiency, both converging on hyperglycemia through different pathways.
Metabolic Biochemistry and Nutrition
Fuel metabolism shifts predictably between the fed and fasting states, and Step 1 questions often ask which pathway or enzyme dominates at a given time point. In the fed state, insulin promotes glycogen synthesis, fatty acid synthesis, and protein synthesis. Early fasting relies on glycogenolysis (breakdown of liver glycogen); after roughly 12 to 24 hours, gluconeogenesis (synthesis of new glucose from lactate, glycerol, and amino acids, primarily in the liver) becomes dominant, and prolonged starvation shifts the brain to using ketone bodies, produced from fatty acid oxidation in the liver, sparing muscle protein breakdown. Key enzyme deficiencies illustrate biochemical logic well: for example, deficiency of glucose-6-phosphatase (von Gierke disease) prevents the final step of both glycogenolysis and gluconeogenesis from releasing free glucose, causing severe fasting hypoglycemia despite normal or increased glycogen stores. Vitamin deficiencies are tested by matching a clinical picture to a specific vitamin's biochemical role: thiamine (B1) deficiency impairs pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, both requiring thiamine pyrophosphate, producing Wernicke-Korsakoff syndrome in the setting of alcohol use; niacin (B3) deficiency causes pellagra, classically remembered as diarrhea, dermatitis, and dementia; vitamin C deficiency impairs collagen synthesis (proline and lysine hydroxylation), producing scurvy with poor wound healing and bleeding gums; and vitamin K deficiency impairs gamma-carboxylation of clotting factors II, VII, IX, and X, prolonging the prothrombin time. Obesity and metabolic syndrome are increasingly tested through the lens of insulin resistance, in which excess adipose tissue (particularly visceral fat) secretes inflammatory adipokines that impair insulin signaling in muscle and liver, linking obesity mechanistically to type 2 diabetes, hypertension, and dyslipidemia.
Pharmacology: GI, Hormonal, and Metabolic-Targeted Drugs
GI pharmacology centers on acid suppression and motility. Proton pump inhibitors irreversibly block the H+/K+-ATPase on parietal cells, providing the most potent and durable acid suppression, used for peptic ulcer disease, GERD, and as part of H. pylori eradication regimens. H2 receptor antagonists block histamine's stimulatory effect on parietal cells, offering less potent suppression. Antiemetics work through distinct receptor mechanisms: ondansetron blocks serotonin (5-HT3) receptors, metoclopramide blocks dopamine (D2) receptors and also promotes gastric motility (with tardive dyskinesia as a feared side effect), and scopolamine blocks muscarinic receptors for motion sickness. Endocrine and metabolic drugs are tested by mechanism at the receptor or enzyme level: metformin decreases hepatic gluconeogenesis and improves peripheral insulin sensitivity without directly stimulating insulin release, so it does not typically cause hypoglycemia on its own; sulfonylureas close ATP-sensitive potassium channels on pancreatic beta cells, depolarizing the cell and triggering insulin release regardless of glucose level, which is why they can cause hypoglycemia; GLP-1 receptor agonists enhance glucose-dependent insulin secretion, slow gastric emptying, and promote satiety; and SGLT2 inhibitors block glucose reabsorption in the proximal tubule, causing glucosuria. Levothyroxine replaces thyroid hormone in hypothyroidism, while thionamides like methimazole block thyroid peroxidase, inhibiting new hormone synthesis for hyperthyroidism. Oral contraceptives combine estrogen and progestin to suppress the hypothalamic-pituitary-gonadal axis, preventing the LH surge and thus ovulation; understanding that suppression of GnRH pulsatility is the shared mechanism behind hormonal contraception ties this back to the axis physiology covered earlier in the chapter.
Key terms
- Intrinsic factor
- — A glycoprotein secreted by gastric parietal cells that is required for vitamin B12 absorption in the terminal ileum.
- Crohn disease
- — An inflammatory bowel disease causing transmural inflammation with skip lesions anywhere from mouth to anus, often with fistulas and granulomas.
- Unconjugated bilirubin
- — The albumin-bound, water-insoluble form of bilirubin produced from heme breakdown before hepatic conjugation by UDP-glucuronosyltransferase.
- Portal hypertension
- — Elevated pressure in the portal venous system, typically from cirrhosis, causing varices, splenomegaly, ascites, and caput medusae.
- GnRH pulsatility
- — The pulsatile hypothalamic release of gonadotropin-releasing hormone that drives LH and FSH secretion and, when suppressed, prevents ovulation.
- Negative feedback (HPT/HPA axis)
- — The regulatory mechanism by which a peripheral hormone (thyroid hormone, cortisol) suppresses upstream pituitary and hypothalamic signals.
- Gluconeogenesis
- — Hepatic synthesis of new glucose from lactate, glycerol, and amino acids, dominant after roughly 12 to 24 hours of fasting.
- Ketone bodies
- — Fuel molecules produced from hepatic fatty acid oxidation during prolonged fasting, used by the brain when glucose is scarce.
- Thiamine (B1) deficiency
- — A vitamin deficiency impairing pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, causing Wernicke-Korsakoff syndrome, often linked to alcohol use.
- Proton pump inhibitor
- — A drug class that irreversibly blocks the parietal cell H+/K+-ATPase, producing potent and durable gastric acid suppression.
- Sulfonylurea
- — An oral diabetes drug that closes ATP-sensitive potassium channels on pancreatic beta cells, triggering insulin release independent of glucose level.
- Metabolic syndrome
- — A cluster of insulin resistance, visceral obesity, hypertension, and dyslipidemia linked mechanistically through inflammatory adipokine signaling.
Exam tips
- Use the pattern of GI disease (continuous mucosal vs. transmural skip lesions) rather than symptoms alone to separate ulcerative colitis from Crohn disease — the distribution and depth of inflammation are the tested facts.
- For bilirubin questions, first decide unconjugated vs. conjugated, then map to a mechanism: production/uptake/conjugation problems raise unconjugated bilirubin, while excretion or obstruction problems raise conjugated bilirubin.
- For any axis (HPT, HPA, HPG), find the low or high hormone that resulted from feedback and reason backward to where the defect sits — a suppressed TSH with high T4 means the problem is at the thyroid, not the pituitary.
- Know what fuel source dominates at each fasting time point (glycogenolysis first, then gluconeogenesis, then ketogenesis) — vignettes often specify a duration of fasting to cue the expected pathway.
- Distinguish insulin secretagogues (sulfonylureas, risk of hypoglycemia) from insulin sensitizers (metformin, low hypoglycemia risk) by mechanism, not just drug class name.